Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience.
Adcock L, Macleod C, Dubay D, Greig PD, Cattral MS, McGilvray I, Lilly L, Girgrah N, Renner EL, Selzner M, Selzner N, Kashfi A, Smith R, Holtzman S, Abbey S, Grant DR, Levy GA, Therapondos G. Adcock L, et al. Among authors: selzner m, selzner n. Am J Transplant. 2010 Feb;10(2):364-71. doi: 10.1111/j.1600-6143.2009.02950.x. Am J Transplant. 2010. PMID: 20415904 Free article.
Hepatic artery chemotherapy and colorectal liver mestastases.
Clavien PA, Dahm F, Selzner N, Selzner M. Clavien PA, et al. Among authors: selzner m, selzner n. Lancet. 2003 May 17;361(9370):1742-3; author reply 1743. doi: 10.1016/s0140-6736(03)13341-7. Lancet. 2003. PMID: 12767760 No abstract available.
Can genetic variations predict HCV treatment outcomes?
Selzner N, McGilvray I. Selzner N, et al. J Hepatol. 2008 Oct;49(4):494-7. doi: 10.1016/j.jhep.2008.07.006. Epub 2008 Jul 21. J Hepatol. 2008. PMID: 18692270 Free article. No abstract available.
The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD, Grant D, Levy G, Renner EL. Selzner N, et al. Among authors: selzner m. Liver Transpl. 2008 Dec;14(12):1778-86. doi: 10.1002/lt.21598. Liver Transpl. 2008. PMID: 19025914 Free article.
The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.
Shalev I, Wong KM, Foerster K, Zhu Y, Chan C, Maknojia A, Zhang J, Ma XZ, Yang XC, Gao JF, Liu H, Selzner N, Clark DA, Adeyi O, Phillips MJ, Gorczynski RR, Grant D, McGilvray I, Levy G. Shalev I, et al. Among authors: selzner n. Hepatology. 2009 Feb;49(2):387-97. doi: 10.1002/hep.22684. Hepatology. 2009. PMID: 19085958
195 results